Microcirculatory effects of a course of the flyuktuorez mexidol in patients with chronic generalized periodontitis of moderate severity

M. A Amkhadova; Anna Vladimirovna P’yanzina; M. Yu Gerasimenko; M. M Gamzatov; M. I Soykher; Z. R Muzaeva

doi:10.17816/dent.39381

Russian Journal of Dentistry ›› 2015, Vol. 19 ›› Issue (5) : 22 -25. DOI: 10.17816/dent.39381

Articles

research-article

Microcirculatory effects of a course of the flyuktuorez mexidol in patients with chronic generalized periodontitis of moderate severity

Author information +

History +

PDF

Abstract

The results of monitoring for 160 patients aged 35 to 75 years with a verified diagnosis of chronic generalized periodontitis of moderate severity. It is established that flyuktuorez helps to improve values for clinical and rheographic indices and indicators of laser Doppler flowmetry by improving microcirculation. It is shown that the rate of flyuktuorez mildronata beneficial effects on myogenic regulation, and flyuktuorez nivalin - neurogenic regulation of vascular tone. Flyuktuorez Actovegin is quite effective in cases where it is not revealed the predominance of violations of either myogenic or neurogenic regulation.

Keywords

chronic generalized periodontitis / flyuktuorez / Actovegin / Mildronate / nivalin

Cite this article

Download citation ▾

M. A Amkhadova, Anna Vladimirovna P’yanzina, M. Yu Gerasimenko, M. M Gamzatov, M. I Soykher, Z. R Muzaeva. Microcirculatory effects of a course of the flyuktuorez mexidol in patients with chronic generalized periodontitis of moderate severity. Russian Journal of Dentistry, 2015, 19(5): 22-25 DOI:10.17816/dent.39381

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Дмитриева Л.А. Пародонтит. М.: Медпресс-информ, 2007.

[2]	Кречина Е.К. Мониторинг реактивности микрососудов пародонта с помощью лазерной допплеровской флоуметрии. Применение лазерной допплеровской флуометрии в медицинской практике: Материалы третьего Всероссийского симпозиума. М.; 2000: 133-4.

[3]	Ушакова Г.Б. Применение флюктуирующих токов в комплексной терапии пародонтита: Дисс. … канд. мед. наук. М.; 1990.

[4]	Buchmayer F., Pleiner J., Elmlinger M.W., Lauer G., Nell G., Sitte H.H. Actovegin®: a biological drug for more than 5 decades. Wien Med. Wochenschr. 2011; 161(3-4): 80-8.

[5]	Jaudzems K., Kuka J., Gutsaits A., Zinovjevs K., Kalvinsh I., Liepinsh E., Liepinsh E., Dambrova M. Inhibition of carnitine acetyltransferase by mildronate, a regulator of energy metabolism. J. Enzyme Inhib Med Chem. 2009; 24(6): 1269-75.

[6]	Osborn G.G., Saunders A.V. Current treatments for patients with Alzheimer disease. J. Am. Osteopath Assoc. 2010; 110(9 Suppl 8): 16-26.

[7]	Petersen P.E., Ogaw H. Strengthening the prevention of periodontal disease: the WHO approach. J. Periodontol. 2005. 76(12): 2187-93.

[8]	Pupure J., Isajevs S., Skapare E., Rumaks J., Svirskis S., Svirina D., Kalvinsh I., Klusa V. Neuroprotective properties of mildronate, a mitochondria-targeted small molecule. Neurosci Lett. 2010; 470(2): 100-5.